Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04390737
Title A Phase I Study to Evaluate the Safety and Clinical Activity of HH2853.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors ShangHai HaiHe Pharmaceutical
Indications

non-Hodgkin lymphoma

Advanced Solid Tumor

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

HH2853

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.